269 related articles for article (PubMed ID: 27925473)
1. The role of cancer stem cells in tumor heterogeneity and resistance to therapy.
Konrad CV; Murali R; Varghese BA; Nair R
Can J Physiol Pharmacol; 2017 Jan; 95(1):1-15. PubMed ID: 27925473
[TBL] [Abstract][Full Text] [Related]
2. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
Mashima T
Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
[TBL] [Abstract][Full Text] [Related]
3. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
5. Approaches for targeting cancer stem cells drug resistance.
Rosa R; D'Amato V; De Placido S; Bianco R
Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
[TBL] [Abstract][Full Text] [Related]
6. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
7. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
9. Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.
Ryoo IG; Lee SH; Kwak MK
Oxid Med Cell Longev; 2016; 2016():2428153. PubMed ID: 26682001
[TBL] [Abstract][Full Text] [Related]
10. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.
Makena MR; Ranjan A; Thirumala V; Reddy AP
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165339. PubMed ID: 30481586
[TBL] [Abstract][Full Text] [Related]
12. Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
Naik PP; Das DN; Panda PK; Mukhopadhyay S; Sinha N; Praharaj PP; Agarwal R; Bhutia SK
Oral Oncol; 2016 Nov; 62():122-135. PubMed ID: 27865365
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
Lee SH; Reed-Newman T; Anant S; Ramasamy TS
Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
[TBL] [Abstract][Full Text] [Related]
14. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Shibue T; Weinberg RA
Nat Rev Clin Oncol; 2017 Oct; 14(10):611-629. PubMed ID: 28397828
[TBL] [Abstract][Full Text] [Related]
15. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in solid tumors.
Ailles LE; Weissman IL
Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
[TBL] [Abstract][Full Text] [Related]
17. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
18. Targeting cancer stem cells for more effective therapies: Taking out cancer's locomotive engine.
Winquist RJ; Boucher DM; Wood M; Furey BF
Biochem Pharmacol; 2009 Aug; 78(4):326-34. PubMed ID: 19539800
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells: A brief review of the current status.
Kuşoğlu A; Biray Avcı Ç
Gene; 2019 Jan; 681():80-85. PubMed ID: 30268439
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer stem cells: opportunities and challenges.
Chhabra R
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]